The University of Cambridge and Elan Corporation today announced the launch of The Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre), which will be located at the University. The Cambridge-Elan Centre will provide a highly interdisciplinary environment uniquely positioned for delivering world-leading translational research focused on innovative therapies for Alzheimer's and Parkinson's diseases. This ten-year agreement paves the way for a long-term collaboration between Elan and the University of Cambridge.
The holidays are a time when family and friends come together and share memories, laughs and good cheer. But for families living with Alzheimer's, the holidays can also be a difficult time.
Caregiving responsibilities layered on top of keeping up with holiday traditions can take its toll on Alzheimer famliies, especially the caregiver. The person with Alzheimer's may also feel a sense of loss during the holidays.
With some planning and adjusted expectations, your celebrations can be filled with joy and magical moments to cherish forever.
A new study found that high blood pressure and other known risk factors for stroke may also raise the risk of developing cognitive problems. The finding suggests that keeping blood pressure under control might help preserve cognitive health.
As federal officials and other experts work toward developing the first-ever national plan that will address the growing crisis of Alzheimer's disease, the Alzheimer's Foundation of America (AFA) is encouraging Americans to take their own steps to be proactive about memory health by taking advantage of free memory screenings during its National Memory Screening Day (NMSD) on November 15.
The Alzheimer's Foundation of America (AFA) is calling on teens to create a short video that creatively expresses their personal stories related to Alzheimer's disease as part of its 2nd annual AFA Teens Video Competition.
The unique competition asks teens to record a two-minute video that gives thoughtful consideration to "a moment in relation to Alzheimer's disease when you learned something about your understanding of the disease, learned something about caregiving, or decided to become a community volunteer/activist."
George Eberhardt turned 107 last month, and scientists would love to know how he and other older folks like him made it that far. So he's going to hand over some of his DNA. He's one of 100 centenarians taking part in a project announced Wednesday that will examine some of the oldest citizens with one of the newest scientific tools: Whole-genome sequencing, the deciphering of a person's complete collection of DNA.
Declaring that our nation "has no time to waste," the Alzheimer's Foundation of American (AFA) today released specific, hard-hitting recommendations on both care and cure to tackle Alzheimer's disease - and urged swift implementation of a national strategy on this growing public health crisis that threatens an increasing number of American families, including aging baby boomers, and the nation's budget.
Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School (HMS) is launching the Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists, and clinicians to explore together how drugs work in complex systems.